← Eichor
Study identifier: NCT06424756 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effects of an Antioxidant Supplement on Blood Vessel Health

Condition: Healthy  ·  Sponsor: University of Georgia

PhasePhase 2
Planned participants60
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersYes

About this study

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, and the non-Hispanic Black (NHB) population is disproportionately affected. Our research has previously demonstrated that oxidative stress may contribute to reduced vascular function in otherwise healthy NHB adults, potentially predisposing them to the development of hypertension and CVD. This study is designed to examine whether the mitochondria are an important source of oxidative stress-induced vascular dysfunction in healthy NHB adults.

This description comes directly from the study's public registry record.

Talk to the study team

S. Tony Wolf  ·  706-542-4378  ·  stwolf@uga.edu

Melissa Gorejena  ·  mgorejena@uga.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Ramsey Student Center, University of GeorgiaAthens, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06424756